Doses Of The Adjuvanted Are Available For Use In Adolescents Upon The Centers For Disease Control And Prevention'S (Cdc) Recommendation, The Company Noted. Novavax Says The Us Food And Drug Administration (Fda) Has Granted Expanded Emergency Use Authorisation For Its Covid-19 Vaccine Adjuvanted For Adolescents Aged Between 12- 17 Years. The Us Company Said The Vaccine Was The First Protein-Based Covid19 Jab Authorised In The Us, Dpa News Agency Reported. Doses Of The Adjuvanted Are Available For Use In Adolescents Upon The Centers Disease Control And Prevention'S (Cdc) Recommendation, The Company Noted. In July 2022, The Fda Had Granted Emergency Use Authorisation For A Two-Dose Primary Series In Adults Aged 18 Years And Older, Followed By A Recommendation From The Cdc Advisory Committee On Immunisation Practices, And Endorsement From The Cdc.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!